formoterol

The drug is intended for maintenance therapy in adult patients to relieve the symptoms of chronic obstructive pulmonary disease (COPD).

Form: powder for inhalation

ATC: R03AL05

Manufacturer: Industrias Farmaceuticas Almiral S.A.

The drug is intended for the regular treatment of bronchial asthma in adults and adolescents (from 12 years old), as well as for the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD).

Form: powder for inhalation

ATC: R03AK07

Manufacturer: Orion Corporation

The drug is intended for the regular treatment of bronchial asthma in adults, adolescents, and children aged 6 years and older. It is used for both maintenance therapy and symptom relief.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: Orion Corporation (full-cycle manufacturing)

The drug is intended for the regular treatment of bronchial asthma in adults and adolescents (from 12 years old), as well as for the symptomatic treatment of chronic obstructive pulmonary disease (COPD) in adults from 18 years old.

Form: powder for inhalation

ATC: R03AK07

Manufacturer: Orion Corporation (full-cycle manufacturing)

The drug is intended for maintenance therapy in adult patients to relieve the symptoms of chronic obstructive pulmonary disease (COPD).

Form: powder for inhalation

ATC: R03AL05

Manufacturer: Industrias Farmaceuticas Almiral S.A.

The drug is prescribed to adults and children from 12 years of age for the regular treatment of bronchial asthma, and to adults from 18 years of age for the symptomatic treatment of chronic obstructive pulmonary disease (COPD).

Form: powder, inhalation, metered

ATC: R03AK07

Manufacturer: Aeropharm GmbH (manufacturing in bulk, primary and secondary packaging, testing, batch release)

The drug is prescribed to adults and children from 12 years of age for the regular treatment of bronchial asthma, as well as to adults from 18 years of age for the symptomatic treatment of chronic obstructive pulmonary disease (COPD).

Form: powder, inhalation, metered

ATC: R03AK07

Manufacturer: Aeropharm GmbH (manufacturing in bulk, primary and secondary packaging, testing, batch release)

The drug is prescribed for adults and children from 12 years of age for the regular treatment of bronchial asthma, as well as for adults from 18 years of age for the symptomatic treatment of severe chronic obstructive pulmonary disease (COPD).

Form: aerosol, metered for inhalation

ATC: R03AK07

Manufacturer: Medispray Laboratories Pvt. Ltd.

The drug is used for the treatment of bronchial asthma (as an adjunct to corticosteroids) and to reduce symptoms of airway obstruction in chronic obstructive pulmonary disease (COPD).

Form: aerosol, suspension for inhalation

ATC: R03AC13

Manufacturer: Cipla Ltd. (Unit II)

The drug is used for the treatment of bronchial asthma (as an adjunct to corticosteroids) and to reduce symptoms of airway obstruction in chronic obstructive pulmonary disease (COPD).

Form: powder for inhalation

ATC: R03AC13

Manufacturer: Orion Corporation

The drug is used to relieve airway obstruction in chronic obstructive pulmonary disease (COPD). Fortex is also prescribed for the treatment of bronchial asthma (specifically nocturnal attacks and exercise-induced symptoms) in patients who are already receiving inhaled corticosteroids.

Form: powder for inhalation, hard capsules

ATC: R03AC13

Manufacturer: Laboratorios Likonsa, S.A.

The drug is prescribed for the regular treatment of bronchial asthma. It is used either for continuous maintenance or for both prevention and rapid relief of symptoms.

Form: powder, inhalation, metered

ATC: R03AK07

Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)

The drug is prescribed to adults and children from 12 years of age for the regular treatment of bronchial asthma, as well as to adults from 18 years of age for the symptomatic treatment of chronic obstructive pulmonary disease (COPD).

Form: powder, inhalation, metered

ATC: R03AK07

Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)

The drug is prescribed for the regular treatment of bronchial asthma in adults and children aged 12 years and older, as well as for the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD).

Form: powder, inhalation, metered

ATC: R03AK07

Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)

The drug is intended for the maintenance therapy of adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) if other combination therapies do not provide sufficient effect.

Form: inhalation, suspension under pressure

ATC: R03AL11

Manufacturer: AstraZeneca Dunkerque Production (manufacturing, primary packaging, secondary packaging, quality control and batch release)

The drug is used for the prevention and treatment of bronchospasm in bronchial asthma, as well as for the prevention and treatment of airway obstruction disorders in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps prevent bronchospasm caused by allergens, physical exertion, or cold air.

Form: capsules, containing powder for inhalation

ATC: R03AC13

Manufacturer: JSC "Adamed Pharma" (manufacturer responsible for batch release, manufacturer of primary and secondary packaging)